The estimated Net Worth of Keith Bradley is at least $917 Thousand dollars as of 18 May 2018. Keith Bradley owns over 2,609 units of Integra Lifesciences Corp stock worth over $536,835 and over the last 21 years he sold IART stock worth over $114,909. In addition, he makes $265,052 as Independent Director at Integra Lifesciences Corp.
Keith has made over 9 trades of the Integra Lifesciences Corp stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 2,609 units of IART stock worth $30,343 on 18 May 2018.
The largest trade he's ever made was exercising 15,658 units of Integra Lifesciences Corp stock on 23 February 2018 worth over $282,783. On average, Keith trades about 471 units every 51 days since 2003. As of 18 May 2018 he still owns at least 30,502 units of Integra Lifesciences Corp stock.
You can see the complete history of Keith Bradley stock trades at the bottom of the page.
Dr. Keith Bradley Ph.D. serves as Independent Director of the Company. He has been a director of the Company since 1992. Between 1996 and 2003, he was a director of Highway Insurance plc, an insurance company listed on the London Stock Exchange, and has been a consultant to a number of business, government and international organizations. Dr. Bradley was formerly a visiting professor at the Harvard Business School, Wharton and UCLA, a visiting fellow at Harvard’s Center for Business and Government and a professor of international management and management strategy at the Open University and Cass Business School, U.K. Dr. Bradley has taught at the London School of Economics and was the director of the School’s Business Performance Group for more than six years. He received B.A., M.A. and Ph.D. degrees from British universities. Dr. Bradley was formerly an adviser to RPH Capital, Canada and a board member of Sensor-Kinesis Corp from 2016 through 2018. He currently serves on the board of directors of SeaSpine Holdings Corporation, until 2019 he was the chair of the compensation committee. In addition, he previously served as a director and chair of North Star Capital Management Limited and GRS Financial Solutions Limited.
As the Independent Director of Integra Lifesciences Corp, the total compensation of Keith Bradley at Integra Lifesciences Corp is $265,052. There are 13 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
Keith Bradley is 75, he's been the Independent Director of Integra Lifesciences Corp since 1992. There are 1 older and 20 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
Keith's mailing address filed with the SEC is 1100 CAMPUS ROAD, , PRINCETON, NJ, 08540.
Over the last 21 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig, and George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: